CINGAL Phase III Data Demonstrates Efficacy and Safety to Treat Knee OA Pain
Phase III study results demonstrated that Anika Therapeutics’ CINGAL® provided superior immediate and short term OA pain relief after injection vs. hyaluronic acid alone, and superior relief at 26 weeks vs. saline. May 23, 2017